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Abstract 
 
      The first part of this work was a survey conducted on the patients 
referred to the Radio immuno assay (RIA) laboratory of Sudan Atomic 
Energy agency (SAEC) 1994-1996. The total number of the referred patients 
during the three years was found to be 4268 subjects, 85% of them were 
referred for the first time. The survey revealed that 87% of the patents 
referred to the lab. were females and 12.6 only were males. The incidence of 
thyroid disorders were found to be also higher in females which comprised 
(33%) of the study group compared to (29%) males. The analysis of blood 
lipids which was conducted in 120 females, to compare clinical hyperthyroid 
patients to subclinical cases, showed significant variations between the 
hyperthyroid group and the euthyroid one. This was presented as 
significantly lower levels of the total cholesterol and the lipoprotein 
cholesterols, LDL-C and HDL-C, in hyperthyroid patients, compared to 
euthyroid group, with significantly higher levels of triacylglyecerols in the 
euthyroid group. The subclinical cases showed very low levels of the LDL-C 
and significantly higher levels of the triacylglycerols with similar value of 
the total cholesterols and the HDL-C compared to the euthyroid group. 
Results indicated that lipid metabolism in subclinical hyperthyroid cases was 
slightly affected by the hormonal disorder. 
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 ﺍﺠﺭﻱ ﻋﻠﻲ ﺍﻟﻤﺭﻀﻲ ﺍﻟﻤﺤﻭﻟﻴﻥ ﺇﻟﻲ ﻤﺨﺘﺒﺭ ﻷﻭل ﻤﻥ ﻫﺫﺍ ﺍﻟﻌﻤل ﻜﺎﻥ ﻤﺴﺤﺎﹰﺍﻟﺠﺯﺀ ﺍ
ﻡ ﻭﻜﺎﻥ ﺍﻟﻌﺩﺩ 6991- ﻡ 4991ﺍﻟﻤﻨﺎﻋﺔ ﺍﻹﺸﻌﺎﻋﻴﺔ ﺍﻟﺘﺎﺒﻊ ﻟﻬﻴﺌﺔ ﺍﻟﻁﺎﻗﺔ ﺍﻟﺫﺭﻴﺔ ﺍﻟﺴﻭﺩﺍﻨﻴﺔ ﻋﺎﻡ 
. ﻤﺤﻭل ﻷﻭل ﻤﺭﺓ% 58 ﺤﺎﻟﺔ ﻤﻨﻬﻡ 8624ﺍﻟﻜﻠﻲ ﻟﻠﻤﺭﻀﻲ ﺍﻟﻤﺤﻭﻟﻴﻥ ﺨﻼل ﺍﻷﻋﻭﺍﻡ ﺍﻟﺜﻼﺜﺔ 
 ﺍﻟﻤﺤﻭﻟﻴﻥ ﺇﻟﻲ ﺍﻟﻤﺨﺘﺒﺭ ﻫﻡ ﻤﻥ ﺍﻟﻨﺴﺎﺀ ﻭﺍﻥ ﻤﻥ ﺍﻟﻤﺭﻀﻲ% 78ﻭﻗﺩ ﻜﺸﻑ ﺍﻟﻤﺴﺢ ﻋﻥ ﺃﻥ 
 ﺍﻟﻐﺩﺩ ﺍﻟﺩﺭﻗﻴﺔ ﺃﻋﻠﻲ ﻟﺩﻱ ﺕﻓﻘﻁ ﻫﻡ ﻤﻥ ﺍﻟﺭﺠﺎل ﻜﻤﺎ ﻭﺠﺩ ﺃﻥ ﻨﺴﺒﺔ ﺍﻀﻁﺭﺍﺒﺎ % 6.21ﻨﺴﺒﺔ 
ﻭﻗﺩ ﺃﻅﻬﺭﺕ . ﻤﻥ ﺍﻟﺭﺠﺎل% 92ﻤﻥ ﻤﺠﻤﻭﻋﺔ ﺍﻟﺩﺭﺍﺴﺔ ﻤﻘﺎﺭﻨﺔ ﻤﻊ % 33ﺍﻟﻨﺴﺎﺀ ﺤﻴﺙ ﻴﻤﺜل 
ﻘﺎﺭﻨﺔ ﻤﺭﻀﻲ  ﻤﻥ ﺍﻟﻨﺴﺎﺀ، ﻟﻤ021ﻨﺘﺎﺌﺞ ﺘﺤﻠﻴل ﺍﻷﺤﻤﺎﺽ ﺍﻟﺩﻫﻨﻴﺔ ﻓﻲ ﺍﻟﺩﻡ ﺍﻟﺫﻱ ﺍﺠﺭﻱ ﻋﻠﻲ 
 ﺍﻟﻐﺩﺓ ﺍﻟﺩﺭﻗﻴﺔ ﺍﻟﺤﺎﺩ ﺃﻟﺴﺭﻴﺭﻱ ﻤﻊ ﺍﻟﺤﺎﻻﺕ ﻏﻴﺭ ﺍﻟﺴﺭﻴﺭﻴﺔ، ﺃﻅﻬﺭﺕ ﺍﺨﺘﻼﻓﺎﺕ ﺕﺍﻀﻁﺭﺍﺒﺎ
ﻭﺍﻀﺤﺔ ﺒﻴﻥ ﻤﺠﻤﻭﻋﺔ ﺍﻻﻀﻁﺭﺍﺏ ﺍﻟﺤﺎﺩ ﻤﻊ ﻤﺠﻤﻭﻋﺔ ﺍﻟﻐﺩﺓ ﺍﻟﺩﺭﻗﻴﺔ  ﺍﻟﺴﻠﻴﻤﺔ ﻭﻗﺩ ﻋﺭﻀﺕ 
ﻜﻤﺴﺘﻭﻴﺎﺕ ﺸﺩﻴﺩﺓ ﺍﻻﻨﺨﻔﺎﺽ ﻤﻥ ﻜﻤﻴﺔ ﺍﻟﻜﻠﺴﺘﺭﻭل ﻭﺍﻟﻜﻠﺴﺘﺭﻭل ﺍﻟﻤﺫﺍﺏ ﺤﺎﻤل ﺍﻷﺤﻤﺎﺽ 
 ﻓﻲ ﻤﺭﻀﻲ ﺍﻀﻁﺭﺍﺏ ﺍﻟﻐﺩﺓ ﺍﻟﺩﺭﻗﻴﺔ ﺍﻟﺤﺎﺩ C-LDH ﻭ C-LDL ﺍﻟﺩﻫﻨﻴﺔ ﻓﻲ ﺍﻟﺩﻡ ، ﻤﺜل
ﻤﻘﺎﺭﻨﺔ ﺒﻤﺠﻤﻭﻋﺔ ﺍﻟﻐﺩﺓ ﺍﻟﺩﺭﻗﻴﺔ ﺍﻟﺴﻠﻴﻤﺔ ﻤﻊ ﻤﺴﺘﻭﻴﺎﺕ ﻋﺎﻟﻴﺔ ﻤﻥ ﺜﻼﺜﻲ ﺍﻟﺠﻠﺴﺭﺍﻴﺩ ﻓﻲ ﻤﺠﻤﻭﻋﺔ 
  ﻭﻗﺩ ﺃﻅﻬﺭﺕ ﺍﻟﺤﺎﻻﺕ ﻏﻴﺭ ﺍﻟﺴﺭﻴﺭﻴﺔ ﻤﺴﺘﻭﻴﺎﺕ ﻤﻨﺨﻔﻀﺔ  ﻤﻥ. ﺍﻟﻐﺩﺓ ﺍﻟﺩﺭﻗﻴﺔ ﺍﻟﺴﻠﻴﻤﺔ
 ﻤﻤﺎﺜﻠﺔ ﻤﻥ ﺍﻟﻜﻠﺴﺘﺭﻭل ﺍﻟﻜﻠﻲ ﻭ   ﻭﻤﺴﺘﻭﻴﺎﺕ ﻋﺎﻟﻴﺔ ﻤﻥ ﺍﻟﺜﻼﺜﻲ ﺍﻟﺠﻠﺴﺭﺍﻴﺩ ﻤﻊ ﻗﻴﻡC-LDL 
ﻓﻲ ﺤﺎﻻﺕ ﺍﻀﻁﺭﺍﺒﺎﺕ ﺍﻟﻐﺩﺓ ﺍﻟﺩﺭﻗﻴﺔ .   ﻤﻘﺎﺭﻨﺔ ﻤﻊ ﻤﺠﻤﻭﻋﺔ ﺍﻟﻐﺩﺓ ﺍﻟﺩﺭﻗﻴﺔ ﺍﻟﺴﻠﻴﻤﺔC-LDH
  .  ﺍﻟﺤﺎﺩﺓ ﻏﻴﺭ ﺍﻟﺴﺭﻴﺭﻴﺔ ﺘﺄﺜﺭﺕ ﻗﻠﻴﻼ ﺒﺎﻻﻀﻁﺭﺍﺒﺎﺕ  ﺍﻟﻬﺭﻤﻭﻨﻴﺔ
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  1
  Introduction 
Thyroid hormones have a substantial role in regulating different 
pathways of metabolism hence they are called metabolic hormones. The 
function of thyroid gland in turn is under the control of the pituitary gland 
through the thyroid stimulating hormone (TSH). The thyroid hormones 
maintain the level of metabolism in the tissues that is optimum for their 
normal function; they are well known to stimulate the oxygen consumption of 
most of the cells in the body, help to regulate lipid and carbohydrates 
metabolism, modulation of gonadotropin secretion by the pituitary and 
maintenance of proliferative cell growth and maturation in hair. In addition, 
thyroid hormones stimulate both sodium pump and glycolytic pathway 
leading to calorigenesis and oxidative phosphoralytion in tissues such as liver, 
kidney, and muscle (Ganong, 1997).   
Physiological concentrations of thyroid hormones exert both anabolic 
and catabolic effects promoting the normal metabolic turn-over, but higher 
concentrations exert catabolic responses. Disorders of the thyroid gland lead 
to disturbances in the different pathways that are regulated by its secretion 
(Murray et al, 2000). More secretion of thyroid hormones (hyperthyroidism) 
leads to body wasting, nervousness, tachycardia, tremor, muscle weakness 
(thyrotoxic myopathy) and excess heat production (Ganong, 1997). 
Subclinical thyroid dysfunction is a common clinical problem for which there 
are many controversial issues regarding screening, evaluation, and 
management. Subclinical hyperthyroidism and hypothyroidism have subtle 
clinical manifestations at most, and the importance of timely diagnosis and 
treatment continue to be contentious subjects of research studies, position 
papers, and editorials. Both Subclinical hyperthyroidism and subclinical 
 hypothyroidism have many clinical implications that can be seriously harmful 
if not treated. These include: progression to overt hypo and hyperthyroidism, 
cardiovascular diseases, atria fibrillation, osteoporosis and bone fracture 
(Helfand, 2004). 
According to Tunbridge et al. (1977) and Hak et al. (2000), subclinical 
disorders are found to be common and twice as often in women as in men, this 
is one of reasons of targeting females in this study (Tunbridge et al., 1977 and 
Hak et al., 2000). Also females are more likely to have clinical thyroid 
diseases (Murray et al, 2000) and this is the second reason for selecting them 
for this study. It is well known that women have more lipids compared to men 
(Murray et al, 2000) and this is the third and last reason for choosing them for 
this research as we expect good image about how lipid metabolism is affected 
by disorders of the thyroid gland. However, in this research, women who are 
suffering from either clinical or subclinical hyperthyroidism; are going to be
  3
2. To estimate the levels of lipid profiles from blood samples of Sudanese 
females that are either suffering from clinical or subclinical hyperthyroid 
function compared to euthyroid Sudanese females. 
3. To detect the effect of clinical and subclinical thyroid dysfunction on the 
lipid metabolism.  
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CHAPTER ONE 
Literature review 
1. The Thyroid gland 
 The human thyroid gland originates from the 4th and 5th branchial 
pouches, which fuse into a single structure and this tissue is present in all 
vertebrates and lies in humans at the root of the neck in front of the upper 
rings of the trachea. The gland has two lobes, right and left which are 
connected by an isthmus. Normal thyroid weight about 20 to 30 grams. 
Histologically, the gland consists of a multitude of follicles which are 
surrounded by connective tissue and filled with colloid. When the gland is 
active the follicles are small and the cells are cuboids while in inactive gland 
  5
1.1.1 Iodine metabolism 
Thyroid hormones are unique in that they require the trace element 
iodine for biologic activity. A complex mechanism has evolved to acquire and 
retain this crucial element and to convert it into a form suitable for 
incorporation into organic compound. The thyroid is able to concentrate I⎯ 
against a strong electrochemical gradient. This active transport system allows 
the human thyroid gland to maintain a concentration of free iodide 30-40 
times that in plasma (Williams, 2001). The transport mechanism is frequently 
called the "iodide- trapping mechanism" or "iodide pump". The pump is an 
example of secondary active transport (Ganong, 1997).  A very small amount 
of iodide enters the thyroid by diffusion. Also any intracellular I⎯ that is not 
incorporated into monoiodotyrosine (MIT) or diiodtyrosine (DIT) is free to 
leave by this mechanism (Murray et al, 2000). 
Two thirds of the absorbed iodine is excreted in the urine within 2 to 3 days 
after ingestion, and may also be lost in the faeces, sweat and milk. Most of 
this iodine comes from the endant process and is linked to the ATPase-
dependant Na+/K+ pump which in turn controlled primarily by TSH (Murray 
et al, 2000). I⎯ is transported across the basement membrane of the thyroid 
cell by an intrinsic membrane molecule called the Na+/I⎯ symporter (NIS). 
The NIS derives its energy from Na+/K+ ATPase, which derives the tarns 
breakdown of thyroid hormones (Williams, 2001). The recommendations of 
the World Health Organization (WHO) for optimal daily iodine intake are as 
follows: 150 µg for adults, 200 µg during pregnancy and lactation, and 50 µg 
for the first year of life and increases as the age increases up to the adult dose 
(Greenspan and Gardner, 2004).  
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1.1.2 Thyroglobulin   
Thyroglobulin is a large glycoprotein molecule containing 5496 amino 
acids. It contains about 140 tyrosyl residues and about 10% carbohydrate. 
Thyroglobulin is unique among body proteins in its content of iodinated 
amino acids (Taurgo, 1978). The greatest part of iodine in the thyroid glands 
of animals on adequate iodine intake exists in the form of thyroglobulin. The 
iodotyrosines "T4 and T3 precursor" form the most abundant iodinated amino 
acid components of thyroglobulin.  
 
.1.3 Proteolysis of thyroglobulin and thyroid hormone secretion 
Thyr globulin is aprohormone . Thyroglobulin is synthesized in the
basal portion of the cell and moves to the lumen, where it is stored in the 
extracellular colloid and reenters the cell and moves in an apical to basal 
direction during its hydrolysis into the active T3 and  T4 hormones. 
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µg of T4/dl. TBG binds about 10% of the circulating T4. Its affinity for T3 is 
about 10 fold lower than for T4, so that it mostly carries T4. Albumin has one 
strong binding site for T4 and T3 and several weaker ones. Because of its high 
concentration in serum, albumin carries about 15% of circulating T4 and T3 
(Williams, 2001). 
 
1.1.5 Metabolism of thyroid hormones 
 The daily secretion of the normal thyroid gland is about 100 nmole of 
T4, about 5 nmole of T3, and less than 5 nmole of metabolically inactive 
reverseT3 (rT3) (Williams, 2001). T4 and T3 are deiodinated mainly in the 
liver, the kidney, and many other tissues. Two different enzymes are involved, 
5 ́-deiodinase catalyzing the formation of T3, which is three to eight times 
more potent than T4, and 5-diodinase catalyzing the formation of r-T3, which 
is metabolically inert. T3 and r-T3 are then converted to various 
diiodothyronines (Ganong, 1997). Monodeiodination of the outer ring of 
thyroxine is a "step up" process; increasing the metabolic activity of the 
resultant compound, while monodeiodination of the inner ring is a "step 
down" or inactivation process. Further deiodination of the molecule abolishes 
normal activity. Most peripheral target tissues utilize T3 that is derived from 
the circulating hormone. Notable exceptions are the brain and pituitary, for 
which local generation of T3 is a major source for the intracellular hormone 
(Hardman and Limbird, 2001).                                                
 
1.2 Physiologic effects of thyroid hormones 
Thyroid hormones considered as metabolic hormones that affect all 
organs development and physiology. 
Cardiovascular effects: Thyroid hormones improve the cardiac 
muscle contractility, increasing diastolic tone of the heart so it has marked 
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Conclusions 
Form this project we come to a conclusion that lipid profile is 
affected by the status of the thyroid gland; where in hyperthyroid females 
the levels of all the fractions were shown to be significantly decreased due to 
the overactivity of the thyroid gland while in subhyperthyroid glands only 
triglycerides was found to be significantly decreased and the others were not 
affected and this can be explained by the fact that subclinical hyperthyroid 
affects the level of TSH but not the T4 and T3; and the later is the active 
hormones in metabolism. 
Recommendations 
1- To the RIA, of SAEC; to modify the registration form for the referred 
patients to include tribe, original residence, family history of the disease, 
economical status. 
2- To make sure that age, sex and treatment are fully addressed. 
3- To make use of samples to conduct research in the biochemistry and 
physiology of human being after getting the permission. 
4- To do lipid profile testing for patients who have clinical or subclinical 
thyroid functions. 
  
 
 
 
positive entropic effect on the heart. This accounts for the increased cardiac 
output and marked increase in the heart rate. 
Haematopoitic effects: The increas d cellular demand for oxygen in 
hyperthyroidism leads to increased production of erythropoietin. However, 
blood volume is usually not increased because of hemodiliution and increased 
red cells turnover (Greenspan and Gardner, 2004). 
Gastrointestinal effects: They stimulate gut motility. This may also 
contribute to the modest weight loss in hyperthyroidism (Greenspan and 
Gardner, 2004).     
Skeletal effects: They stimulate increased bone turnover, increased 
bone resorption thus chronic hyperthyroidism may result in significant 
osteoponia and in severe cases modest hypercalcemia and hypercalciuria 
(Ganong, 1997).  
Neuromuscular effects: Thyroid hormones increase the number and affinity of
  9
minutes in a hyperthyroid patients and about 150 minutes in hypothyroid 
patients (Greenspan and Gardner; 2004). 
 
 
1. 3 Hyperthyroidism; thyrotoxicosis 
Over-activity of thyroid gland is a clinical syndrome produced by 
sustained high plasma concentrations of thyroid hormones, may be easy to 
diagnose clinically or may remain unsuspected for a long time. It affects 2-5% 
of all females at sometime and with a sex ratio of 5:1 most often between ages 
20-40 years. Nearly all cases (99%) are caused by intrinsic thyroid disease; a 
pituitary cause is extremely rare (Kumar and Klark, 2002, Longmore et al, 
2001).  
 
1.3.1 Causes of hyperthyroidism 
? Graves' disease. The cause of most hyperthyroidism is Graves' 
disease, an autoimmune disorder in which antibodies produced by 
immune system stimulate thyroid to produce too much thyroxine. 
Normally, immune system uses antibodies to help protect against viruses, 
bacteria and other foreign substances that invade body. In Graves' 
disease, antibodies mistakenly attack thyroid gland and occasionally the 
tissue behind the eyes and the skin of lower legs over the shins. Scientists 
aren't sure exactly what causes Graves' disease, although several factors - 
including a genetic predisposition - are likely involved.  
? Hyperfunctioning thyroid nodules (toxic adenoma, toxic 
multinodular goiter, Plummer's disease). This form of 
hyperthyroidism occurs when one or more adenomas of thyroid produce 
too much thyroxine. An adenoma is a part of the gland that has walled 
itself off from the rest of the gland, forming noncancerous (benign) 
 
abnormalities.  Worthy to be noted, most of researchers and authors focused 
on other implications that related to subclinical hyperthyroidism. These 
include atrial fibrillation, osteoporosis, and cardiovascular diseases.  
As mentioned before, the literature on assessment and treatment of 
patients with subclinical hyperthyroidism is markedly less extensive. The 
precise pathophysiology, natural history, prevalence, risks and long-term 
outcome of subclinical hyperthyroidism are unknown. Diane and Kenneth, 
(2002) reported that in the United States, subclinical hyperthyroidism 
became an entity that is increasingly recognized, probably of the aging of the 
Untied States population and the development of assays with enhanced TSH 
sensitivity. 
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Cholesterol level (172,7±31).In case of subclinical hyperthyroid female 
Cholesterol level was the same as the result found in the euthyroid females 
and this due to the fact that subclinical  hyperthyroid subjects have normal 
level  of T4 and T3 and hence normal function at the thyroid hormones. These 
finding agree with Caparevic et al,(2000). Also in this study there was no 
significance differences in all groups regarding the HDL-Cholesterol or LDL-
Cholesterol level. These results to some extent are not surprising, since many 
studies, concerning patients with overt hyperthyroidism, reported that 
hyperthyroidism is associated with decreased or normal concentrations of total 
cholesterol and the other serum lipoproteins and lipids. Moreover, Hanson, 
(1983) studied the effect of experimental hyperthyroidism on plasma 
lipoproteins and stated that, the decreased LDL-cholesterol concentrations in 
hyperthyroid patients may be due to a mechanism include both an increased 
number of LDL-receptors and enhanced transfer of cholesterol and 
phospholipids to the LDL sub-fraction with subsequent rapid uptake in the 
liver via hepatic lipase. Another study carried by Caparevic et al, (2000) 
included 55 elderly patients with subclinical hyperthyroidism, concluded that 
patients with subclinical hyperthyroidism tend to have low serum total 
cholesterol, LDL-cholesterol and HDL-cholesterol levels. Also they found 
significant increase of serum cholesterol, LDL-cholesterol and HDL-
cholesterol levels after treatment.  
Relaying on these findings above, and the fact that thyroid hormones 
could increase lipolysis, it is fairly expected that the levels of serum lipids in 
patients with supbclinical hyperthyroidism are decreased or at the normal 
range. In this study, subjects with subclinical hyperthyroidism, to some 
extent, are found to be having normal serum lipids, suggesting that there 
might not be relationship between subclinical hyperthyroidism and lipids 
 
lumps that may cause an enlargement of the thyroid. Not all adenomas 
produce excess thyroxine,  
? Thyroiditis. The inflammation can cause excess thyroid hormone 
stored in the gland to leak into bloodstream. One rare type of thyroiditis, 
known as subacute thyroiditis, causes pain in the thyroid gland. Other 
types are painless and may sometimes occur after pregnancy (postpartum 
thyroiditis) (Kumar and Klark, 2002). 
1.3.2 Risk factors 
Being female, women are ten times more likely to develop an 
overactive thyroid than men. On the other hand Graves’ disease is more likely 
in people whose close relatives are affected. Having other autoimmune 
disease, such as type I diabetes, vitiligo and Addison’s disease, increase the 
chance of getting hyperthyroidism (Kumar and Klark, 2002).  
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instituted without biochemical confirmation. Differentiation of the mild case 
from anxiety states may be difficult; useful positive clinical markers are: eye 
signs, a diffuse goiter, proximal myopathy and wasting, and hyper dynamic 
circulation with warm peripheries (Kumar and Clark, 2002).  
Biochemical investigations 
Serum TSH is suppressed in hyperthyroidism (< 0.05 mU/l) except 
for the very rare instances of TSH hyper-secretion. Diagnosis is confirmed 
with a raised serum T4, free T4 or T3. T4 is almost always raised but T3 is more 
sensitive as there are occasional cases of isolated T3 toxicosis. 
Thyroperoxidase (TPO) and thyroglobulin antibodies are present in most 
cases of Graves’ disease. TSH receptors antibodies are not measured 
routinely, but are commonly present. Thyroid stimulating immunoglobulin 
(TSI) in 80% is positive, TSH-binding inhibitory globulin (TBIG) 60-90% in 
Graves’ disease (Kumar and Clark, 2002).  
Table (1): Shows the symptoms of hyperthyroidism 
Metabolic effects of thyroid 
hormones 
Increased sympathetic 
activity 
Unknown mechanism 
Weight loss Nervousness Goiter 
Muscular weakness Palpitation Opthalamopathy 
Hair loss Heat intolerance  
Thin skin Sweating  
Onycholysis Tremor  
 
According to (Greenspan and Gardner, 2004)  
 
 
4.2 Thyroid Status 
This study was designed to compare the level of some serum lipid 
parameters (Cholesterol, TG, LDL-Cholesterol and HDL-Cholesterol) in 
hyperthyroid and sub clinical hyperthyroid patients com ared to euothyroid 
subjects. In the present study found that serum T3 with mean values 1,97 ,2,19 
,and 7,4 nmol/L for euthyroid,subclinical and clinical hyperthyroid females 
respectively. While the mean values for T4 were found to be 94,30 ,103,3,and 
231,0nmol/L for euothyroid ,subclinical and clinical hyberthyroid females 
respectively. These finding were in agreement with level reported by Series et 
al ,(1988).In this study subject that considered as subclinical hyperthyroid 
cases have obviously suppressed TSH level . Diana and Kenneth ,(2002) 
reported that the level of subclinical hyperthyroidism is due to the sensitivity 
of pituitary gland to respond to minor elevation in serum or tissue T4 and 
T3 Athough the level of T3 and T4 remain within the normal range minimal
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Chapter Four  
Discussion 
4.1 Survey  
 Almost 15% of the Sudanese females referred to RIA laboratory 
of SAEC during 1994 to 1996 were found to be under treatment which is the 
same results found in males bearing in mind that 87% of the referred 
patients were females and this is in a good agreement with what has been 
published (Suklar et al, 2000). 71.4% of the males were found to have 
euthyroid compared to 67.1% among the females who visited the laboratory 
in the same period that means females are more susceptible for thyroid 
disorders compared to the males. Those who had hyper active thyroid among 
the males were found to represent only 73 patients of 13.5% compared to 
407 patients of 10.9% among the females. Subclinical hyperthyroid was 
found to be only 25 patients of 3.0% among the males and 93 patients of  
2.3% among the females that is more or less the same percent of incidence. 
To have a comprehensive study with regard to the study of the prevalence of 
these disorders; a detailed register should contain many parameters in 
addition to the data used to collect from the referred patients: that includes 
residence, tribe, family history for the disease or any endocrine disorder, 
treatment and any other informative data that can be used to reduce the risk 
factors and hence improve the quality of the lives for those who are under 
risk 
 
 
 
 
1.4 Subclinical hyperthyroi ism 
 Subclinical hyperthyroidism is defined as persistently suppressed serum 
TSH with normal thyroxine and triiodothyronine in patients who do not have 
symptoms (Kek et al, 2003). 
 While the diagnostic criteria and treatment modalities for overt 
hyperthyroidism are well known, the literature on assessment and treatment of 
patients with subclinical hyperthyroidism is markedly less extensive. The 
precise pathophysiology, natural history, risks and long-term outcome of 
subclinical hyperthyroidism are unknown (Diane and Kenneth, 2002). 
 The prevalence of subclinical hyperthyroidism varies amongst the 
reports. To date, there is no definitive information about the incidence of 
subclinical hyperthyroidism in the general population. Its prevalence ranges 
from 0.6 to 16% depending on diagnostic criteria, the sensitivity of the 
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1.4.1 Causes 
 Most patients with subclinical hyperthyroidism are ambulatory 
outpatients who are otherwise relatively healthy or have stable, chronic 
medical conditions. Abnormalities in the TSH remain for months or years in 
the absence of overt clinical symptoms (Diane and Kenneth, 2002). 
 The most common causes of subclinical hyperthyroidism are excessive 
thyroid hormone therapy. The causes can be endogenous as Graves' (early in 
its course) or it can be caused by thyroid conditions such as autonomous 
adenoma, multi-nodular goiter, or thyroiditis, or due to nonthyriodal 
conditions: euthyroid sick syndrome, acute psychiatric disease, pituitary and 
hypothalamic disorders, pregnancy, and drugs: thyroxine dopamine, 
glucocorticoids, aspirin and furosemide (Kek et al, 2003). In patients with 
toxic adenoma or multi-nodular goiter, subclinical hyperthyroidism is usually 
a slowly progressive disorder and may last several years before being 
diagnosed (Biondi et al., 2005). 
 
1.4.2 Clinical implications 
Increasingly, it is recognized that subclinical hyperthyroidism is not 
merely a biochemical abnormality dissociated from the clinical manifestations 
and squeal of thyrotoxicosis. In fact, clinical features of thyrotoxicosis can be 
identified in subclinical hyperthyroidism albeit of insufficient severity to 
cause major symptoms. The clinical significance of subclinical 
hyperthyroidism thus relates to three risk factors: progression to overt 
hyperthyroidism, cardiac effect, and skeletal effects (Kek et al., 2003). 
 
1.5 Lipids 
The term lipids apply to a class of compounds that are soluble in 
organic solvents and nearly insoluble in water. Chemically, lipids are either 
 
 
 
Figure (21): The prevalence of LDL-cholesterol (mg/dl) in th  euthyroid and 
Hyp rthyroid Sudanese females. 
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Figure (20): The mean values of LDL-cholesterol (mg/dl) in the euthyroid and 
hyperthyroid Sudanese females.   
 
 
 
 
compounds that yield fatty acids on hydrolysis or complex alcohols that can 
combine with fatty acids to form esters. Some lipids contain non-lipids groups 
such as sialie, phosphpryl, amino or sulphate groups. The presence of these 
groups gives lipids molecules affinity for both water and organic solvents. 
This affinity is important in the formation of biological membranes (Ganong, 
1997).  
 
1.5.1 Classification of lipids 
Lipids can be subdivided broadly into five groups: 
1. Sterol derivatives: cholesterol and cholesterol esters, steroid hormones, bile 
acids, and vitamin D.  
2. Fatty acids: short chain, medium chain, long chain, and prostaglandins.  
3. Glycerol esters: tri-di- and mono-, glycerides; and phosphoglycerides.  
4. Sphingosine derivatives: sphingomyecein and glycosphingolipids. 
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the plasma lipoproteins and between cell membranes and lipoprotein, yet 
strong enough to allow the various classes and subclasses of lipoproteins to be 
isolated by a variety of analytical techniques.  
 
Classifications 
Lipoproteins have been categorized into five classes according to their 
physical and chemical properties and according to their chemical composition 
(%) as shown in table (2).  
 Lipoprotein metabolism  
The pathways of lipoprotein metabolism are complex. The way 
these lipoproteins are organized into an exogenous pathway, which transport 
lipids from the intestine to the liver, and endogenous pathway, which transport 
lipid to and from the tissues.  
1. Exogenous pathway: lipoproteins in this pathway of dietary origin. 
Chylomicrons are formed in the intestinal mucosa during the absorption of the 
products of fat digestion. They are very large lipoprotein complexes that enter 
the circulation via the lymphatic ducts. Chylomicrons are cleared from the 
circulation by the action of lipoprotein lipase which catalyzed the break down 
of triglyceride in the chylomicrons to fatty acids and glycerol, which then 
enter adipose cells and are reesterified. Chylomicrons depleted of their 
triglyceride remain in the circulation as cholesterol –rich lipoproteins called 
chylomicrons remnants, which are carried to the liver where they bind to LDL 
receptors and internalized by receptor mediated endocytosis and are degraded 
in lysosomes.          
         Endogenous pathway: This system made up of VLDL, IDL, LDL and 
HDL which transports triglycerides and cholesterol throughout the body. 
VLDLs are formed in the liver and transport triglycerides to extrahepatic 
 
 
 
 
 
Figure (19): The prevalence of HDL-cholesterol (mg/d)/l in the euthyroid and 
hyperthyroid Sudanese females. 
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Figure (18): The mean values of HDL-Cholesterol (mg/dl) in the euthyroid 
and hyperthyroid Sudanese females. 
         
  
  
  
  
 
 
 
 
 
 
 
 
 
 
tissues. Triglycerides are removed by the action of lipoprotein lipase; they 
become IDL the IDL give up phospholipids and through the action of the 
plasma enzyme lecithin cholesterol acyltransferase (LCAT) pick up 
cholesterol esters formed from HDL. The remaining IDL lose more 
triglyceride and protein and become LDL. LDL provide cholesterol to the 
tissue and taken up by receptor-mediated endocytosis (Tiez et al, 2001). LDLs 
are also taken up a lower –affinity system in the macrophages and some other 
cell (Ganong, 1997). 
 
Table (2): The percentage of different complements for each lipoprotein 
 
 
 
 
 
  Composition%  
Lipoprotein Cholesterol Phospholipids Apolipoproteins Triglyceride Cholesteryl esters
Chylomicrons  2 3 2 90 3
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1.5.1.2 Glycerol esters 
Glycerol is a three-carbon alcohol with a hydroxyl group on each of 
its carbon atoms. The class of acylglycerol (glyceride) is determined by the 
number of fatty acyl groups present; one fatty acid (mono acylglycerol), two 
fatty acids (diglycerides) or three fatty acids (triglycerides). In human 
nutrition; triglycerides constitute 95% of tissue storage fat and are the 
predominant form of glyceryl ester found in plasma (Murray et al, 2000).  
Metabolism 
Triglycerides are digested in the duodenum and proximal ileum, 
through the action of pancreatic and intestinal lipases and in the presence of 
bile acid. They are hydrolyzed to glycerol, monoglyerides and fatty acids. 
After absorption, triglycerides are re-synthesized in the intestinal epithelial 
cells and combined with cholesterol and apo 3-48 to form chylomicrons, 
which are secreted to the lymphatic system, travel through the thoracic duct 
and eventually reach the blood stream through the jugular vein (Murray et al, 
2000).  
Familial hypertriglyceridema 
A moderate increase in the concentration of serum triglycerides is 
characteristic of familial hypertriglyceridema (FHTG). The production of 
large VLDL-Cholesterol with abnormally high triglyceride content appears to 
be responsible for this disorder. The cholesterol content of VLDL-Cholesterol 
also increased but plasma LDL-Cholesterol and apo B-100 concentrations are 
within their reference intervals. This finding suggests that the conversion of 
VLDL-Cholesterol to LDL-Cholesterol is not increased in these individuals. 
Furthermore, plasma HDL-Cholesterol in those with FHTG often decreased 
dramatically, probably secondary to the hypertriglyceridema. The cause of the 
 
 
 
 
Figure (17): The prevalence of total cholesterol (mg/dl) in the euthyroid and 
hyperthyroid Sudanese females. 
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Figure (16): The mean values of TC (mg/dl) in the euthyroid and hyperthyroid 
Sudanese females. 
        
  
  
  
 
 
 
 
 
 
 
 
 
 
 
overproduction of VLDL-Cholesterol triglycerides is currently is unknown. 
The diagnosis of familial hypertriglyceridema (FHTG) requires study of other 
family members to differentiate this disorder from FCHL. This disorder 
appears to be inherited in an autonomic dominant pattern.  
1.5.2 Effects of hyperthyroidism on lipids metabolism 
Alterations of the lipid profile are well known phenomena in thyroid 
dysfunction. Thyroid hormones regulate lipid metabolism through various 
mechanisms. Increased thyroid hormone levels stimulate fat mobilization, 
leading to increased concentrations of fatty acids in plasma. They also 
enhance oxidation of fatty acids in many tissues. Finally, plasma 
concentrations of cholesterol and triglycerides are inversely correlated with 
thyroid hormone levels (Spandrio et al., 1993).   
It has been known for over fifty years that an increase in thyroid 
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individuals who have a cholesterol level greater than 34 mIu/ml and low 
thyroxine 45 nmol/l this data suggesting that thyroid dysfunction may make a 
significant contribution to hypercholesterolemia in general population (Series 
and Biggart, 1988). A study carried out by Duntas and Leonidas, (2002) 
showed that hyperthyroidism exhibits an enhanced excretion of cholesterol 
and increased turn over of LDL resulting in a decreased total and LDL-
cholesterol, whereas HDL is decreased or not affected. Also, the composition 
and the transport of lipoproteins are seriously disturbed in thyroid diseases. 
Rassoul, et al., (1988) postulated that clinical manifestation of hypothyroidism 
lead to changes of plasma lipoproteins, which are characterized by elevated 
LDL-cholesterol, an increase of the ratio of LDL-cholesterol/ HDL-
cholesterol. On the contrary patients with hyperthyroidism showed low 
lipoproteins levels (Rassoul et al., 1988). Also Duntas and Leonidas, (2002) 
reported that, there is a marked increase in HDL levels in hyperthyroid 
patients due to increased activity of (CETP) and hepatic lipase (HL) which are 
regulated by thyroid hormones. They suggested that the low activity of 
(CETP) and more specifically of (HL), results in reduced transport of 
cholesteryl esters from HDL to VLDL and IDL and reduces transport of 
HDL2 to HDL3 (Duntas and Leonidas, 2002). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
Figure (15): The prevalence of TG (mg/dl) in the euthyroid and hyperthyroid 
Sudanese females. 
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Figure (14): The mean values of TG (mg/dl) in the euthyroid and hyperthyroid 
Sudanese females 
       
 
CHAPTER TWO 
Materials and Methods 
2.1 The Survey 
       A general survey was carried out for the records of thyroid function test to 
subjects visited the SAEC laboratories during 1994-1996. The study focused 
on the variation in sex, age and subject's status, whether they were new cases 
or under treatment this is related to their thyroid status. The statistical analysis 
was done using statistical package for social science (spss) and excels 
software of Microsoft 
 
2.2 The effect of clinical and subclinical hyperthyroidism on lipids  profile  
2.2.1 Subjects 
One hundred and twenty adult female patients their ages ranging between
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and stored at -20 C ْfor the determination of triglycerides and total cholesterol 
and its fractions. 
2.3 Reagents 
The levels of TSH, T4, and T3 were estimated by using 
Radioimmunoassay (RIA) techniques, (RIA) kits are all supplied by the 
Department of Isotopes, China Institute of Atomic Energy, 1994. Each Kit has 
specific code: IMK-437, IMK-438, and IMK-432 for T4, T3, and TSH 
respectively.   
 
 2.3.1 T4 kits 
 Each kit consisted of 6 vials of lyophilized standards of T4 to give 
different concentrations when reconstituted by 1 ml of distilled water; (0, 26, 
52, 103, 206, and 309 nmole/l thyroxin). One vial of T4-I125 tracer and T4 
antibodies coupled to magnetic particles, and one vial for quality control 
sample (QC).  
 
 2.3.2 T3 kit 
Each one includes 6 vials of triiodothyronine, standard solution in 
different concentrations, (0, 0.5, 1.0, 2.0, 4.0, 8.0 nmol/l 
triiodothyronine). One vial contains T3-I125 tracer, one vial Anti-T3 antibody, 
and one vial of QC sample.  
 
  2.3.3 Thyroid stimulating hormone (TSH) kit 
Each kit contains 7 vials of standard solution of TSH which has the 
following concentrations: 0.0, 0.23, 1.0, 3.0, 10.0, 20.0 and 80.0 mIU/ml. One 
vial contains anti-TSH antibodies that has been coupled to magnetic particles; 
solid phase separation system. One vial of tracer (labeled anti TSH with I125), 
one vial wash Buffer, 3 vials of QC samples A, B and C with different ranges. 
 
subclinical hyperthyroid females. Results of high density lipoprotein were 
shown in figures 18 and 19 also table 5 shows the mean values of HDL-
cholesterol. All groups reported levels within the normal range for HDL-C. 
3.2.6 Low density lipoproteins cholesterol 
        LDL-cholesterol showed different results from HDL-cholesterol; 
euthyroid and subclinical hyperthyroid were found to have almost the same 
results where majority of the samples were found to have normal levels of 
LDL-cholesterol with (p>0.05) which means that no significant variation 
while 42.5% of the hyperthyroid females were found to have low levels of 
LDL-cholesterol and 55% of them found to have normal levels. (p<0.001) 
which means that significant variation occurred between the euthyroid and 
subclinical hyperthyroid females. The mean values were found to be 104, 95 
and 75 mg/dl for euthyroid, subclinical hyperthyroid and clinical hyperthyroid 
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hyperthyroid females; results are almost the same as the results found in the 
euthyroid females and this is due to the fact that subclinical hyperthyroid 
subjects have normal levels of T4 and T3 and hence normal functions of the 
thyroid hormones, p value was found to be (p>0.05) which means that there is 
no significant variation between the two groups. The mean values of TC 
levels were found to be 172.7 in the euthyroid females which is the same 
finding in the subclinical hyperthyroid females compared to 141.7 mg/dl in 
case of hyperthyroid females. It is obvious that TC levels are affected by the 
clinical hyperthyroid function, which lead to a decrease in its levels in the 
majority of samples collected from hyperthyroid females; also the mean value 
was found to be less than the lower limit of the normal range. However, 
subclinical hyperthyroid results showed the same results that found in the 
euthyroid females, both of them have mean values that within the normal 
range. The mean values were shown in figures 16 and table 5 while the 
prevalence in the different groups was shown in figure 17. The lowest level of 
TC was reported in the hyperthyroid patients, which was lower than the 
normal range whereas the subclinical cases kept the same value as in the 
euthyroid subjects. 
3.2.5 High density lipoprotein cholesterol 
In case of HDL-cholesterol, significant variation was observed 
between the euthyroid and hyperthyroid females with (p>0.05) and the mean 
values found to be 52.1 and 44.8 mg/dl for euthyroid and clinical hyperthyroid 
females respectively but no significantvariation was found between the 
euthyroid and subclinical hyperthyroid females (p> 0.05) and mean value 
equal to 48.60 mg/dl). These findings showed that thyroid dysfunctions affect 
the levels of HDL-cholesterol among the hyperthyroid females but not the 
 
2.3.4 Reagents for lipids’ measurement  
Commercial enzymatic methods were used for determination of total 
cholesterol, triglycerides, LDL-Cholesterol and HDL-Cholesterol. All kits and 
reagents were supplied by (Biosystems) company, for reagents and 
instruments. Methods and procedures are applied according to the instructions 
described in the kits manuals. Each Kit has specific code: 11570, 11648, 
11579, and 11528 for Cholesterol, HDL-Cholesterol, LDL-Cholesterol and 
TG respectively. 
2.4 Equipments: 
1. Adjustable micropipettes (10-200µl) with disposable tips.  
2. Polystyrene test tubes (disposable).  
3. Vortex mixer (single and multi-tubes).  
4. Multi-dose micropipette. (Eppendorfe).25µl and 250 µl, magnetic base 
(separator).  
5 W t b th
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After mixing well, the tubes were incubated at 37 C ْfor 45 minutes, 
then the rack was placed on the magnetic base for 10 minutes to separate the 
bound fraction from the free fractions by decant the supernatant. Lastly each 
tube was counted in the gamma counter to evaluate the gamma emission per 
minute, and binding percent was plotted vs. the concentration of the 
corresponding standard to get a standard calibration curve, and from this 
curve, thyroxin concentration of the unknown samples can be obtained. This 
method is bioassay method, (Radioimmunoassay), Using radio active isotope 
of iodine (I125) which is gamma emitter (Edward, 1980). 
2.5.2 T3 
Test tubes were labelled in duplicate and arranged in assay rack. 25 
µl of standard solutions, QC samples and patient samples were added to the 
corresponding tub. 250 µl of T3- I125 tracer and 100 µl anti-T3 antibodies were 
added to each tube and mixed. The tubes were incubated at 37 C ْfor one hour 
and then well vortexed and then centrifuged to separate bound fraction; liquid 
phase separation system, the supernatant was decanted and then each tube was 
placed in gamma counter. The principle of the assay is the same as that for T4 
(Edward, 1980). 
 
2.5.3 TSH 
Test tubes were labeled and arranged in assay rack in duplicate. 100 
µl of STD, QC and samples were pipetted in target tubes, 25 µl tracer (anti 
TSH labeled by I125) were added to each tube and vortexed gently, and then 
incubated at 37 C ْ in the incubator for one hour. 250 µl of anti TSH (antibody 
coupled to magnetic particles) was added to each tube and mixed well and 
incubated at 25 C ْ for one hour. Then the racks were placed in the magnetic 
separator for 10 minutes and the supernatant was separated by decantation.     
 
 3.2.3 Results of triglycerides (TG)  
When results of triglycerides were analyzed, 37.5% of the euthyroid 
females were found to have low levels that were less than the lower limit of 
the normal range compared to 57.5% that have normal levels of TG and only 
5% that have high levels of TG. In case of subclinical hyperthyroid females, 
62.5% were found to have normal levels of TG while 37.5% were found to 
have high levels of TG and none of them was found to have low TG. The 
same results were found in the hyperthyroid females. The mean values of TG 
levels were found to be 92.6, 152.9 and 146.1 mg/dl in euthyroid, subclinical 
hyperthyroid and clinical hyperthyroid females respectively. Almost all the 
mean values were found to be within the normal range of TG but statistical 
analysis showed that there is highly significant variation between euthyroid 
and hyperthyroid results (p < 0.001) and the same result was found between 
euthyroid and subclinical hyperthyroid results TG mean values were shown
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Figure (13):  The prevalence of TSH mlu/ml levels among the euthyroid and 
hyperthyroid Sudanese females 
      
 
Washing step 
In this step first the concentrated wash buffer was diluted by adding 
water (1:9), and then 500 µl of the diluted wash buffer was added to each 
tube, vortexed well and then placed again in the magnetic base and allowed to 
stand for 10 minutes. The supernatant was decanted and drained thoroughly 
on adsorbent paper. The wash step was repeated again. All the tubes were 
counted in the gamma counter, to evaluate the concentration of TSH in the 
patient sample. 
The quantitative analysis of TSH is achieved by the above method, 
which is immunoradiometric method. It is non- competitive method in which 
the radio active compound (tracer) is TSH antibody. There are two antibodies 
to react with the TSH in the analyte to get a sandwich complex (Edward, 
1980). 
 
2 5 4 Calc lation of res lts
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2.6.1 Estimation of Total Cholesterol 
Principle of the method 
In the presence of Cholesterol esterase, the cholesterol esters in the 
sample are hydrolyzed to cholesterol and free fatty acids. The cholesterol 
produced is oxidized by Cholesterol oxidase to cholestenone and hydrogen 
peroxide. Hydrogen peroxide is detected by a chromogenic oxygen acceptor, 
phenol- ampyrone, in the presence of peroxidase. The red quinine formed is 
proportional to the amount of cholesterol present in the sample (Tietz et al, 
2000). 
Cholesterol ester + H2O                     CHE          Cholesterol + fatty acid 
Cholesterol + ½ O2 +H2                   CHOD        Cholesterol + H2O2 
2H2O2 + Aminoantipyrine + Phenol      POD         Quinoniemine +4H2O 
Contents and composition of reagents 
1. Reagent-1 (Buffer):  PIPES PH 6.9 90 mmol/l, phonol 26 mmol/l  
2. Reagent-2 (Enzymes): Cholesterol esterase (CHE) 300 U/ml, 
Cholesterol oxidase (CHOD) 300 U/L, Peroxidase (POD) 1250 
U/ml,   4-aminoantipyrine (4-AP) 0.4 mmol/l, pH 7.0.  
3. Cholesterol standard (200 mg/dl).  
Procedure: 
1. The working reagent was prepared by dissolving one vial of Reagent-2 
enzymes in one bottle of reagent-1 Buffer, and then brought to room 
temperature. The following was pipetted 
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Figure (12): The mean values of TSH (mlu/ml) in euthyroid and hyperthyroid 
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Figure (11): The prevalence of T3 (nmol/l) levels among the euthyroid 
hyperthyroid Sudanese females 
  
  
  
  
  
  
  
  
 
 
 
 Blank Standard (ST) Sample (S) 
Cholesterol 
standard 
 10 µl  
Sample - - 10 µl 
Working reagent 1.0 ml 1.0 ml. 1.0 ml 
2. 3- The tubes were incubated for 10 minutes at room temperature (25 C)ْ. 
3. 4- The absorbance (A) of the standard and samples were measured at 
500 nm against the blank.     
Calculations: 
                                     A s × 200  
                                        A std = cholesterol (mg/ dl)  
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Procedure 
Precipitation 
1. Into labeled centrifuge tubes the following were  pipetted:  
Sample 0.2 ml 
Reagent B 0.5 ml 
2. The tubes were left to stand for 10 minutes at room temperature.  
3. Centrifuged at minimum of 4000 r.p.m for 10 minutes.  
4. The supernatant was collected carefully.  
Colorimetry  
1. The cholesterol reagent was brought to room temperature.  
2. Into labeled test tubes the following were pipetted:  
   Blank Standard (ST) Sample (S) 
Distilled water 100 µl - - 
HDL-Cholesterol 
standard 
- 100 µl - 
Sample supernatant - - 100 µl 
Cholesterol reagent 1.0 ml 1.0 ml. 1.0 ml 
3. The tubes were incubated for 10 minutes at 37 C.ْ  
4. The absorbance (A) of the sample and the standard were measured at 
500 nm against the blank.  
Calculations: 
                                 As X 3.5 X 40     
                                        A std 
 
=    HDL-Cholesterol (mg/dl) 
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Figure (10): The mean values of T3 (nmol/l) in the euthyroid and hyperthyroid 
Sudanese females 
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  Figure (9): The prevalence T4 (nmol/l) level among the euthyroid and 
hyperthyroid Sudanese females 
 
 
   
  
  
  
  
  
  
  
  
  
  
 
 
 
0
10
20
30
40
50
60
70
80
90
100
Pre vale nce
Euthyroid Hyper thyroid Subclinical
hyperthyroid
<50
50-150
>150
 
2.6.3 Estimation of Low- density Lipoprotein Cholesterol 
Principle of the method: 
      Low-density lipoproteins in the sample are precipitated with 
ploy vinyl sulphate. Their concentrations are calculated from the difference 
between the serum total cholesterol in the supernatant after centrifugation. 
The cholesterol is spectrophotometerically measured by means of the coupled 
reactions as described in total cholesterol (Tietz, 1999). 
 
Contents and composition of reagents 
1. Reagent B: 10 ml polyvinyl sulphate 3 g/L, polyethylene glycol 3 g/L.  
2. Cholesterol kit (Biosystem code 11505, 11506, 11539).  
 
Procedure 
Precipitation 
1. Into labeled centrifuge tubes the following were pipetted:   
  29
3- The tubes were mixed and incubated at room temperature for 30 
minutes. 
4- The absorbance (A) of the sample and the standard were measured 
at 500 nm against the blank. 
Calculations 
      The dilution factor of the sample in the precipitate is 1.5 and the 
concentration of the standard is 200 mg/dL according to the following formula 
is; 
                                           AS  X 200 
                 AST  
LDL-Cholesterol = Total- cholesterol   -   supernatant’ cholesterol.  
2.6.4 Estimation of Triglycerides 
Principle of the method 
   Triglycerides in the sample originate, by means of the coupled 
reactions described below, a colored complex that can be measured by 
spectrophotometer (Fossati and Precipe, 1982). 
Triglycerides + H2O            lipase                 Glycerol + Fatty acids 
Glycerol + 3ATP       glycerol kinase            Glycerol-3-p + 3ADP   
Glycrtol-3-p + O2       G3p-oxidase        Dihydroxyacetone-p + H2O2  
2H2O2 + 4-Aminoantipyrine + 4-cholesterol    peroxidase Quinoneimine + 4H2O 
Contents and composition of reagents 
1. Reagent A.  PIPES 45mmol/L, magnesium chloride 5mmol/L, 4-
chlorophenol 6mmol/L, lipase > 100 U/ml, glycerol kinase > 1.5 U/ml, 
Cholesterol (mg/dl) =   
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Figure (8): The mean values of T4 in the euthyroid and hyperthyroid Sudanese 
females 
         
 
  
  
  
  
 
  43
(11) show the same results for the T3, and the TSH results were shown in 
figures (12) and (13).  
Table (4): shows the levels of thyroid and thyroid related hormones 
in euthyroid and hyperthyroid Sudanese females Expressed as mean ± SD. 
Thyroid status Thyroxine T3 TSH 
Norml ranges 50-150 nmole/L 0.80-3.0 nmole/L 0.40-4.0 mIu/Ml 
Euthyroid 94.30 c ± 9.97 1.97 c ±0.46 1.60 c  ± 0.54 
Hyperthyroid 231.80a ± 48.49 7.40 a  ± 2.87 0.18 b  ± 0.50 
Subclinical 
hyperthyroid 
103.30 c  ± 15.23 2.19c±0.50 0.18 b  ± 0.08 
• Same letters mean non significant  
• Different letters mean significant across the columns 
 
 
 
 
 
 
 
 
 
glycerol-3-phosphate oxidase > 4 U/ml, peroxidase > 0.8 U/ml, 4-
aminoantipyrine 0.75 mmol/L, ATP 0.9 mmol/L, pH 7.5.  
2. Triglycerides standard. Glycerol equivalent to 200 mg/dl triolein.  
Procedure 
1- The reagent was brought to room temperature. 
2- Into labeled test tubes the following were pipetted: 
  Blank Standard (ST) Sample (S) 
Triglycerides standard - 10µL - 
Sample - - 10µL 
Reagent 1.0Ml 1.0mL 1.0mL 
3- The tubes were incubated for 15 minutes at room temperature. 
4- The absorbance (A) of the standard and sample was measured at 500 nm 
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CHAPTER TREE  
Results 
3.1 The survey  
3.1.1 Statistical analysis of the patients who referred to RIA laboratory, 
of SAEC (1994-1996) 
From 1994 to 1996, 4268 Sudanese patients suspected to have 
thyroid disorders were referred to the RIA laboratory of SAEC for thyroid 
function test; among them 3730 females representing 87.4% compared to 538 
males represent 12.6%. The average age was found to be 31 years as shown in 
figure (2). Almost 85% of the referred patients visited the RIA laboratory for 
the first time as shown in table 3. Figure (1) shows the type of visit to the RIA 
laboratory of SAEC during the period 1994 to 1996. However, figure (3) 
shows the prevalence of clinical and subclinical hyperthyroid compared to the 
euthyroid for both males and females. When analyzing the results by sex, 
males were found to represent 12.6% of the total patients referred to the lab. 
71.4% of them were found to have euthyroid gland, 13.5% had had 
hyperthyroid gland while the subclinical hyperthyroid males were found to 
represent 3% as shown in figure (3), and the rest percent (12.1%) for the 
hypothyroid whether clinical and subclinical. On the other hand, females were 
found to represent 87.4% of the total patients referred to the lab. 67.1% of 
them were found to have euthyroid gland, 10.9% had hyperthyroid gland. 
However, subclinical hyperthyroidism was found to represent 2.3% among the 
studied females, prevalence percentages are shown in figure (3), again and the 
rest percent (19.7%) for the hypothyroid whether clinical and subclinical.  
 
3.2.2 Thyroid function test status in the study group of  Sudanese  females  
A total of one hundred and twenty females were selected to 
participate in the present study 40 hyperthyroid females, equal number fit the 
criteria for subclinical hyperthyroidism cases, and the remaining 40 were 
euthyriod selected as controls. 
Mean values of T4 were found to be equal to 94.30, 103.3 and 231.0 
nmole/L for euthyroid, subclinical hyperthyroid and clinical hyperthyroid 
females respectively, significant variation was found between normal and 
hyperthyroid females for T4 but no significant variation between the normal 
and subclinical hyperthyroid females for T4 (p<0.001) and (p>0.05) 
respectively. T3 results showed 100% agreement in the case of euthyroid and 
subclinical hyperthyroid females while 95% of the hyperthyroid females have 
shown good agreement with literature; the mean values were found to be 1.97, 
2 19 and 7 4 nmole/L for euthyroid subclinical hyperthyroid and clinical
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Figure (7): The percent of each age group for the females who 
participated in the study 
     
 
 
Table (3):  The percentage of males to females of Sudanese subjects 
who visited RIA Lab, SAEC during (1994-1996).  
Under treatment New cases  
No % No % 
 
Total 
Male 80 14.87 458 85.13 538 
Female 544 14.58 3186 85.42 3730 
Total 624 14.71 3644 85.29 4268 
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Figure (1): The percentage for each type of visit to the RIA laboratory for the 
subjects under survey 
   
   
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 3.2 Effect of clinical and subclinical hyperthyroid on lipid in Sudanese 
females 
3.2.1 Age of females under study 
The age of Sudanese females under study were analyzed statistically 
into three groups where 32.5% (39) of them were found to be less than 30 
years old while 34.2% of them have ages ranged between 30 and 39 and 
33.3% of them their ages ranged between 40 and 49 years as shown in 
figure(7). 
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Figure (6): The mean level of TSH (mIu/ml) of euthyroid and hyperthyroid 
subjects under survey 
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Figure (2): The mean of age for subjects under survey 
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Figure (3): The prevalence of hyperthyroid (clinical and subclinical) 
compared to euthyroid among Sudanese population 
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Figure (5): The mean of T3 (nmole/L) of euthyroid and hyperthyroid subjects 
under survey 
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Figure (4): The mean of T4 in (nmole/L) of euthyroid and hyperthyroid 
subjects under survey 
   
  
  
  
  
  
 
 
 
 
 
 
 
 
 
 
Figure (4), (5) and (6) show the mean values of T4, T3 and TSH for 
subjects under survey classified as euthyroid, clinical hyperthyroid and 
subclinical hyperthyroid; the results showed good agreement with the 
definitions of each class.  
